Search

everythinglearnresearchcommunity

for

Search:↓

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

People with androgenetic alopecia are more likely to have metabolic syndrome.

The new treatment was safe and may effectively treat male pattern hair loss.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Balding men have harder scalps.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

Astragaloside A may help fight lung cancer by targeting specific proteins.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Troponin I may help detect heart problems in people with Androgenetic Alopecia.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

The combined therapy significantly increased hair density and was safe for treating hair loss.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Personalized treatment plans are crucial for effectively managing male pattern baldness.

Polyglutamic acid is a valuable, sustainable ingredient for skincare and haircare products.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.